Stock-Based Compensation

6 Months Ended

Jun. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation

Note 8 – Stock-Based Compensation

The Amended and Restated Omnibus Stock and Performance Compensation Plan (the “Omnibus Plan”) permits the issuance of up to 1,500,000 shares of the Company’s common stock in the form of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units and performance awards. The Company issues shares out of treasury stock for these awards. During the six months ended June 30, 2016, 34,925 restricted shares and 0 SARs were granted under the Omnibus Plan.

Restricted Stock

Restricted shares granted prior to April 16, 2013 are amortized to expense over a three-year vesting period. Beginning on April 16, 2013, restricted shares granted to Company employees are amortized to expense over a three-year vesting period whereas restricted shares granted to members of the Board of Directors are amortized to expense over a one-year service period, with the exception of those shares granted in lieu of cash payments for retainer fees which are expensed in the period earned. As of June 30, 2016, the total unrecognized compensation expense related to non-vested restricted shares was $2,591,000, and the related weighted-average period over which it is expected to be recognized is approximately 1.0 years.

Following is a summary of the activity of the restricted stock:

	Six Months Ended
	June 30, 2016
	Shares		Fair Value
Balance at December 31, 2015	69,041		$	51.33
Granted	34,925		$	49.95
Vested	(29,268	)	$	50.93
Balance at June 30, 2016	74,698		$	50.59

SARs

SARs vest over a three-year period, with one-third of the shares vesting and becoming exercisable each year on the anniversary date of the grant, and they expire 10 years from the original grant date. As of June 30, 2016, the total unrecognized compensation expense was $129,000, and the related weighted-average period over which it is expected to be recognized is 0.6 years. Following is a summary of the activity of the Company’s SARs program for the six-month period ended June 30, 2016:

			Weighted-		Average	Aggregate
			Average		Remaining	Intrinsic
			Exercise		Contractual	Value
	Shares		Price		Term Years	(In thousands)
Outstanding at December 31, 2015	307,323		$	36.57	5.99	$	4,577
Exercised	(5,803	)	$	31.96
Outstanding at June 30, 2016	301,520		$	36.66	5.49		4,536
Exercisable at June 30, 2016	289,356		$	35.61	5.40	$	4,657

Following is a summary of the activity of the non-vested SARs during the six-month period ended June 30, 2016:

			Weighted-Average
	Shares		Grant Date Fair Value
Non-vested at December 31, 2015	52,507		$	51.17
Vested	(40,343	)	$	48.02
Non-vested at June 30, 2016	12,164		$	61.64